on 10 Apr 2024
Last Applicant/ Owned by
Xeris Pharmaceuticals, Inc.
180 N LaSalle Street, Suite 1810Chicago IL 60601
US
Serial Number
2320951 filed on 9th Feb 2024
Correspondent Address
NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.
3700 CANTERRA TOWER400 - THIRD AVENUE S.W.CALGARY
ALBERTA
CA
T2P4H2
Trademark usage description
pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnostic radiology use. providing information relating to d Read More12
12
2320951
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 256 on 11th Feb 2025 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 29th Apr 2024 | Agent Changed |
Submitted for opposition 257 on 11th Apr 2024 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 10th Apr 2024 | Created |
Submitted for opposition 31 on 10th Apr 2024 | Formalized |
Submitted for opposition 228 on 9th Feb 2024 | International Registration |
Submitted for opposition 30 on 9th Feb 2024 | Filed |